ICS6 Tokyo Public Conference
Day Two: A day for educating the public and lawmakers
First published on the DailyClout
Dr. Chris Flowers, MD, represented the WarRoom/DailyClout Pfizer and Moderna Documents Analysis Project volunteers at last week's International COVID Summit 6 (ICS6) conference in Tokyo and Japan’s House of Representatives. His focus was on the hidden deaths and clinical trial deletions, which reveal the fraudulent nature of the trial that allowed Pfizer’s BNT162b2 mRNA COVID-19 vaccine to be granted an emergency use authorization (EUA) by the Food and Drug Administration (FDA) in December 2020.
Below are the slides and his testimony script. The exact phrases had to be submitted in advance to allow prior translation, so the language was scripted.
SLIDE 1 The Pfizer Clinical Trials
“My name is Dr. Chris Flowers. I am the medical lead of the WarRoom/DailyClout, where 3,400 volunteers from crowd-sourced citizens review the Pfizer documents under the leadership of Dr. Naomi Wolf. Our reports have been published in two books, and the subject of today’s talk includes the peer-reviewed publication by Team 3 about our forensic examination of the Pfizer clinical trial.”
We are a mixture of medical professionals, from academia, primary care, research backgrounds, nurses, clinical trials specialists, actuaries, and many others.
We are all unpaid volunteers with no conflicts of interest.
We have reviewed every page of the documents released after a Freedom of Information Act request and court order.
SLIDE 2: The Pfizer Clinical Trial C4591001
Our question is, “Can we trust the clinical trials used to approve these modified mRNA vaccines?”
The committee, VRBPAC (Vaccines and Related Biological Products Advisory Committee), recommending this new preventative treatment met on December 10, 2020, and the FDA formally approved Pfizer’s COVID-19 ‘vaccine’ the next day.
A paper about the trial was published the day after approval in the New England Journal of Medicine.
There were nearly 44,000 subjects in the trial divided into two groups – placebo recipients and intervention recipients.
The groups were balanced for age, gender, and demographics – BUT there were MORE deaths in the vaccinated group.
We reviewed all the individual patient case report forms (CRFs) and medical notes of the six months data when they were released by the FDA
The data at six months showed 38 deaths (21 vaccinated, 17 placebo).
At the approval meeting on December 10, 2020, Pfizer reported six deaths (two vaccinated, four placebo).
The CRFs show at least eight deaths at that time (four vaccinated, four placebo).
SLIDE 3: Peer-reviewed published paper on the analysis of the clinical trial deaths
The graph shows the number of deaths over time by week.
The graph also shows the timings of the ‘data cut-off point’ and the date of approval of the emergency use authorization (EUA).
This shows no difference in number of deaths between those getting Pfizer’s BNT162b2 vaccine or the placebo.
After EUA approval, almost all the placebo recipients from the trial received the vaccine, and the deaths among those receiving the vaccine continued to climb.
At no point in the trial was there evidence that this intervention would save people’s lives.
SLIDE 4: Deaths in the C4591001 TRIAL at EUA Approval
Here is a visual presentation of the same data with ALL the data not available at the time of approval.
The reporting of deaths due to the intervention was delayed.
The deaths were NOT disclosed until later.
We found these delays in reporting by reviewing the CRFs and were able to show evidence of two deaths that Pfizer knew about but did not disclose at the time of the data submission for the EUA.
Clinical trial sites were legally obligated to report notifications of death to the sponsor (Pfizer) within 24 hours.
SLIDE 5: Not Only Hidden Deaths But Hidden Autopsies
Out of the 38 total patient deaths in the trial, only seven autopsies were performed (18%).
Out of the 21 deaths in the vaccine arm of the trial, 10 suffered SUDDEN ADULT DEATH (SAD) or were Found Dead (FD).
Only two of these had autopsies. (EVERYONE SHOULD HAVE AN AUTOPSY IN THAT CIRCUMSTANCE.)
Of those, one had a diagnosis of Sudden Adult Death – unknown.
The other was a 53-year-old man found dead in the bathroom by his mother – the CRFs state “RESULT NOT AVAILABLE”! And they are still not publicly available three years later.
SLIDE 6: An example of delayed reporting of results of autopsy
68-year-old female – death NOT publicly disclosed at the time of drug approval.
The subject died on October 19, 2020, and the site was notified the same day by the patient’s emergency contact.
The death was not officially recorded in the CRF until November 25, 2020, a delay of 37 days.
The autopsy result was Sudden Adult Death – cause unknown.
SLIDE 7: Data Cut-Off Point and Delayed Recording of Deaths
There were, in fact, 11 clinical trial deaths at the time of the data cut-off on November 14, 2020.
Only eight of those had been recorded, and only six were disclosed by Pfizer and reported in the New England Journal of Medicine by Polack et al.
The range of delays was from one day to 37 days.
Pfizer recorded 80% of the placebo group deaths and only 33% of the deaths in the vaccinated group.
SLIDE 8: Other Issues with the Trial
DESTRUCTION OF THE PLACEBO GROUP
Placebos are important because they provide a baseline when assessing the long-term safety of a drug.
After the EUA was granted, the placebo group was offered the vaccine, and most placebo participants took it.
By removing the control (i.e., placebo) group, the baseline was removed.
Similarly, in the Pfizer pediatric COVID-19 vaccine trials, the subjects were unblinded and received a third dose, which destroyed the ability to track long-term safety in the children’s trial.
SLIDE 9: Other Issues with the Trial
Women who became pregnant during the Pfizer clinical trial were dropped from the trial without follow-up.
Issues with subject randomization (especially in selected populations – e.g., Argentina).
Large numbers of subjects logged as ‘Discontinued Subjects’ with no follow-up
What happened to 2,100 unblinded placebo subjects?
Missing CRFs: Is Pfizer hiding them, or did they not do the required follow-up?
Information still withheld by Pfizer and why this is critical: autopsies, pregnancy test results, blood cell counts, troponin levels, and more.
Obfuscation of diagnosis: preferred terms, diagnosis inaccuracy, diagnosis alteration/manipulation
The BNT162b2 vaccine granted EUA was a different product from what the vast majority of clinical trial participants received. It also contained unacceptable levels of undisclosed contaminants.
And many more
SLIDE 10: CONCLUSIONS
Pfizer’s COVID-19 vaccine did NOT prevent death.
It was not tested for long-term safety.
The effects on transmission were never studied.
More trial subjects died in the BNT162b2 group than the placebo group.
Smaller than expected number of autopsies in patients who ‘died suddenly.’
Huge numbers of trial subjects were lost to follow-up.
The clinical trial used to justify the public use of this product was flawed and misreported.
Who will be held to account?
The day after my presentation, we proceeded to give the testimony in Japan’s House of Representatives, where a senator and a representative were present, and the session was recorded for use in their parliamentary inquiries.
Here we are leaving the hotel for parliament.
Left to right: John Kage, Jason Christoff, William Makis, James Lindsay, Chris Flowers
Speaking directly to the Senator and Representative present in the room.
A short video set to the amazing playing of Lyrico Sonnleitner (a violinist with the Austrian Symphony Orchestra)
The next post will describe our day in the House of Representatives
Thank you for coming to Japan to share your insight! Hope you enjoyed visiting Japan.
There're a lot of 'grassroots' level movement happening in Japan, attempting to spread information through people to people and heart to heart communication to raise awareness of the harms that have been caused by the injections. Those grassroots people are typically on the streets in Japan and handing out information brochures and talking to passerbys. There are some MDs among those grassroots activists, which is quite unique only to be seen in Japan IMO.... Those MDs are great because they understand the science of it, but I also hope more grassroots activists to be interested in leaning those scientific matters, such as the fraudulent nature of Pfizer trials etc (like in your presentation) so each one of the activist can provide solid evidence when questions arise from unsuspecting people on the streets.
Also, going back in time a little bit..... thank you for providing a message video to the Japanese rally goer for 31st May. I was never involved in the rally itself but I happened to be given your video message to the Japanese people for the 31st rally and had a privilege to create Japanese subtitles ..... it was such an honour to be able to contribute like that. The Japanese people loved the video : )))!!
Thank you for all you do.